TESSENDERLO GROUP (TESB.BR) Fundamental Analysis & Valuation

EBR:TESB • BE0003555639

Current stock price

21 EUR
0 (0%)
Last:

This TESB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TESB.BR Profitability Analysis

1.1 Basic Checks

  • In the past year TESB has reported negative net income.
  • TESB had a positive operating cash flow in the past year.
  • Of the past 5 years TESB 4 years were profitable.
  • In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • TESB has a worse Return On Assets (-3.07%) than 66.67% of its industry peers.
  • TESB has a Return On Equity of -4.80%. This is in the lower half of the industry: TESB underperforms 63.77% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.79%, TESB is in line with its industry, outperforming 47.83% of the companies in the same industry.
  • TESB had an Average Return On Invested Capital over the past 3 years of 2.85%. This is below the industry average of 7.13%.
Industry RankSector Rank
ROA -3.07%
ROE -4.8%
ROIC 2.79%
ROA(3y)0.72%
ROA(5y)4.1%
ROE(3y)1.04%
ROE(5y)7.19%
ROIC(3y)2.85%
ROIC(5y)6.39%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • TESB has a worse Operating Margin (2.82%) than 63.77% of its industry peers.
  • TESB's Operating Margin has declined in the last couple of years.
  • TESB has a Gross Margin of 19.03%. This is in the lower half of the industry: TESB underperforms 76.81% of its industry peers.
  • TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.82%
PM (TTM) N/A
GM 19.03%
OM growth 3Y-38.87%
OM growth 5Y-23.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-7.25%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. TESB.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TESB is destroying value.
  • TESB has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TESB has more shares outstanding
  • TESB has a better debt/assets ratio than last year.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.01 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • TESB has a Altman-Z score (2.01) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of TESB is 2.68, which is a good value as it means it would take TESB, 2.68 years of fcf income to pay off all of its debts.
  • TESB has a Debt to FCF ratio of 2.68. This is amongst the best in the industry. TESB outperforms 89.86% of its industry peers.
  • TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • TESB has a better Debt to Equity ratio (0.06) than 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.68
Altman-Z 2.01
ROIC/WACC0.39
WACC7.22%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that TESB has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.08, TESB is in the better half of the industry, outperforming 68.12% of the companies in the same industry.
  • TESB has a Quick Ratio of 1.12. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
  • TESB has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.12
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TESB.BR Growth Analysis

3.1 Past

  • The earnings per share for TESB have decreased strongly by -294.77% in the last year.
  • TESB shows a small growth in Revenue. In the last year, the Revenue has grown by 4.36%.
  • TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.72% yearly.
EPS 1Y (TTM)-294.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-306.78%
Revenue 1Y (TTM)4.36%
Revenue growth 3Y2.21%
Revenue growth 5Y9.72%
Sales Q2Q%1.36%

3.2 Future

  • Based on estimates for the next years, TESB will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.56% on average per year.
  • Based on estimates for the next years, TESB will show a small growth in Revenue. The Revenue will grow by 3.35% on average per year.
EPS Next Y3.7%
EPS Next 2Y16.73%
EPS Next 3Y14.56%
EPS Next 5YN/A
Revenue Next Year3.96%
Revenue Next 2Y3.94%
Revenue Next 3Y3.35%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. TESB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TESB. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 16.37 indicates a correct valuation of TESB.
  • Based on the Price/Forward Earnings ratio, TESB is valued a bit cheaper than the industry average as 60.87% of the companies are valued more expensively.
  • TESB is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 16.37
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TESB is valued cheaply inside the industry as 97.10% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TESB indicates a somewhat cheap valuation: TESB is cheaper than 75.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.69
EV/EBITDA 3.69
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TESB does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as TESB's earnings are expected to grow with 14.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.73%
EPS Next 3Y14.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. TESB.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.48%, TESB has a reasonable but not impressive dividend return.
  • The stock price of TESB dropped by -20.45% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 2.31, TESB pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, TESB pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.48%

5.2 History

  • The dividend of TESB has a limited annual growth rate of 4.01%.
Dividend Growth(5Y)4.01%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • TESB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of TESB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-55.49%
EPS Next 2Y16.73%
EPS Next 3Y14.56%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

More info and screens

Find the best dividend stocksShow peers with best dividend

TESB.BR Fundamentals: All Metrics, Ratios and Statistics

TESSENDERLO GROUP

EBR:TESB (4/16/2026, 4:17:08 PM)

21

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-01
Earnings (Next)N/A
Inst Owners5.48%
Inst Owner ChangeN/A
Ins Owners68.68%
Ins Owner ChangeN/A
Market Cap1.24B
Revenue(TTM)2.76B
Net Income(TTM)-81.10M
Analysts76.36
Price Target26.52 (26.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.48%
Yearly Dividend0.75
Dividend Growth(5Y)4.01%
DP-55.49%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.7%
PT rev (3m)-4.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-32.2%
EPS NY rev (3m)-27.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.37
P/S 0.45
P/FCF 16.69
P/OCF 5.5
P/B 0.73
P/tB 0.84
EV/EBITDA 3.69
EPS(TTM)-1.33
EYN/A
EPS(NY)1.28
Fwd EY6.11%
FCF(TTM)1.26
FCFY5.99%
OCF(TTM)3.82
OCFY18.2%
SpS46.78
BVpS28.61
TBVpS25.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.07%
ROE -4.8%
ROCE 3.72%
ROIC 2.79%
ROICexc 3.02%
ROICexgc 3.39%
OM 2.82%
PM (TTM) N/A
GM 19.03%
FCFM 2.69%
ROA(3y)0.72%
ROA(5y)4.1%
ROE(3y)1.04%
ROE(5y)7.19%
ROIC(3y)2.85%
ROIC(5y)6.39%
ROICexc(3y)3.1%
ROICexc(5y)7.32%
ROICexgc(3y)3.58%
ROICexgc(5y)8.19%
ROCE(3y)3.8%
ROCE(5y)8.52%
ROICexgc growth 3Y-39.65%
ROICexgc growth 5Y-21.48%
ROICexc growth 3Y-40.25%
ROICexc growth 5Y-21.24%
OM growth 3Y-38.87%
OM growth 5Y-23.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-7.25%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.68
Debt/EBITDA 0.31
Cap/Depr 56.22%
Cap/Sales 5.48%
Interest Coverage 7.79
Cash Conversion 65.01%
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 1.12
Altman-Z 2.01
F-Score5
WACC7.22%
ROIC/WACC0.39
Cap/Depr(3y)77.15%
Cap/Depr(5y)77.84%
Cap/Sales(3y)6.13%
Cap/Sales(5y)5.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-306.78%
EPS Next Y3.7%
EPS Next 2Y16.73%
EPS Next 3Y14.56%
EPS Next 5YN/A
Revenue 1Y (TTM)4.36%
Revenue growth 3Y2.21%
Revenue growth 5Y9.72%
Sales Q2Q%1.36%
Revenue Next Year3.96%
Revenue Next 2Y3.94%
Revenue Next 3Y3.35%
Revenue Next 5YN/A
EBIT growth 1Y22.1%
EBIT growth 3Y-37.51%
EBIT growth 5Y-15.66%
EBIT Next Year221.47%
EBIT Next 3Y57.58%
EBIT Next 5YN/A
FCF growth 1Y-51.31%
FCF growth 3Y-4.9%
FCF growth 5Y-16.41%
OCF growth 1Y-32.26%
OCF growth 3Y4.15%
OCF growth 5Y-4.38%

TESSENDERLO GROUP / TESB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


Can you provide the valuation status for TESSENDERLO GROUP?

ChartMill assigns a valuation rating of 4 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Fairly Valued.


What is the profitability of TESB stock?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 2 / 10.


What is the financial health of TESSENDERLO GROUP (TESB.BR) stock?

The financial health rating of TESSENDERLO GROUP (TESB.BR) is 7 / 10.


What is the expected EPS growth for TESSENDERLO GROUP (TESB.BR) stock?

The Earnings per Share (EPS) of TESSENDERLO GROUP (TESB.BR) is expected to grow by 3.7% in the next year.